tirzepatide vs semaglutide comparison effectiveness side effects vs. for Weight Loss Tirzepatide vs Semaglutide: Key Differences

Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume

Adems, en una encuesta de corte transversal nacional de EE

If hunger remains problematic despite these interventions, referral to an obesity medicine specialist or endocrinologist is appropriate for complex cases

3) Effets secondaires cardio-vasculaires et neurovgtatifs A